30PUpdate on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer. (13th May 2019)

Record Type:: Journal Article
Title:: 30PUpdate on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer. (13th May 2019)
Main Title:: 30PUpdate on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer
Authors:: Smyth, L M
Saura, C
Piha-Paul, S A
Lu, J
Mayer, I A
Brufksy, A M
Spanggaard, I
Arnedos, M
Cutler, R E
Hyman, D M
Abstract:
Is Part Of:: Annals of oncology. Volume 30(2019)Supplement 3
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 3
Issue Display:: Volume 30, Issue 3 (2019)
Year:: 2019
Volume:: 30
Issue:: 3
Issue Sort Value:: 2019-0030-0003-0000
Page Start:
Page End:
Publication Date:: 2019-05-13
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz095.029 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11798.xml